These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 16325051

  • 21. Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury.
    Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler AA.
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):178-87. PubMed ID: 18287886
    [Abstract] [Full Text] [Related]

  • 22. Combining angiogenic gene and stem cell therapies for myocardial infarction.
    Pons J, Huang Y, Takagawa J, Arakawa-Hoyt J, Ye J, Grossman W, Kan YW, Su H.
    J Gene Med; 2009 Sep; 11(9):743-53. PubMed ID: 19554624
    [Abstract] [Full Text] [Related]

  • 23. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
    Lee BL, Kim WH, Jung J, Cho SJ, Park JW, Kim J, Chung HY, Chang MS, Nam SY.
    Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
    [Abstract] [Full Text] [Related]

  • 24. Forensic pathological investigation of myocardial hypoxia-inducible factor-1 alpha, erythropoietin and vascular endothelial growth factor in cardiac death.
    Zhu BL, Tanaka S, Ishikawa T, Zhao D, Li DR, Michiue T, Quan L, Maeda H.
    Leg Med (Tokyo); 2008 Jan; 10(1):11-9. PubMed ID: 17698391
    [Abstract] [Full Text] [Related]

  • 25. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
    Fraccarollo D, Widder JD, Galuppo P, Thum T, Tsikas D, Hoffmann M, Ruetten H, Ertl G, Bauersachs J.
    Circulation; 2008 Aug 19; 118(8):818-27. PubMed ID: 18678774
    [Abstract] [Full Text] [Related]

  • 26. Downregulated expression of plasminogen activator inhibitor-1 augments myocardial neovascularization and reduces cardiomyocyte apoptosis after acute myocardial infarction.
    Xiang G, Schuster MD, Seki T, Witkowski P, Eshghi S, Itescu S.
    J Am Coll Cardiol; 2005 Aug 02; 46(3):536-41. PubMed ID: 16053971
    [Abstract] [Full Text] [Related]

  • 27. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
    Du XJ, Gao XM, Kiriazis H, Moore XL, Ming Z, Su Y, Finch AM, Hannan RA, Dart AM, Graham RM.
    Cardiovasc Res; 2006 Sep 01; 71(4):735-43. PubMed ID: 16859660
    [Abstract] [Full Text] [Related]

  • 28. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice.
    Kitahara T, Takeishi Y, Harada M, Niizeki T, Suzuki S, Sasaki T, Ishino M, Bilim O, Nakajima O, Kubota I.
    Cardiovasc Res; 2008 Oct 01; 80(1):40-6. PubMed ID: 18558628
    [Abstract] [Full Text] [Related]

  • 29. Hypoxia-Inducible Factor 1 alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Pathway Participates in Angiogenesis of Myocardial Infarction in Muscone-Treated Mice: Preliminary Study.
    Du Y, Ge Y, Xu Z, Aa N, Gu X, Meng H, Lin Z, Zhu D, Shi J, Zhuang R, Wu X, Wang X, Yang Z.
    Med Sci Monit; 2018 Dec 08; 24():8870-8877. PubMed ID: 30531686
    [Abstract] [Full Text] [Related]

  • 30. Gene therapy with hypoxia-inducible factor 1 alpha in skeletal muscle is cardioprotective in vivo.
    Czibik G, Gravning J, Martinov V, Ishaq B, Knudsen E, Attramadal H, Valen G.
    Life Sci; 2011 Mar 14; 88(11-12):543-50. PubMed ID: 21238463
    [Abstract] [Full Text] [Related]

  • 31. Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart.
    Huang Y, Hickey RP, Yeh JL, Liu D, Dadak A, Young LH, Johnson RS, Giordano FJ.
    FASEB J; 2004 Jul 14; 18(10):1138-40. PubMed ID: 15132980
    [Abstract] [Full Text] [Related]

  • 32. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P, Seifert H, Gao E, Funakoshi H, Völkers M, Heierhorst J, Remppis A, Pleger ST, DeGeorge BR, Eckhart AD, Feldman AM, Koch WJ.
    Circulation; 2006 Sep 19; 114(12):1258-68. PubMed ID: 16952982
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
    Loinard C, Ginouvès A, Vilar J, Cochain C, Zouggari Y, Recalde A, Duriez M, Lévy BI, Pouysségur J, Berra E, Silvestre JS.
    Circulation; 2009 Jul 07; 120(1):50-9. PubMed ID: 19546390
    [Abstract] [Full Text] [Related]

  • 34. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
    Tian H, Cimini M, Fedak PW, Altamentova S, Fazel S, Huang ML, Weisel RD, Li RK.
    J Mol Cell Cardiol; 2007 Dec 07; 43(6):733-43. PubMed ID: 17945252
    [Abstract] [Full Text] [Related]

  • 35. Neovascularization and cardiomyocytes regeneration in acute myocardial infarction after bone marrow stromal cell transplantation: comparison of infarct-relative and noninfarct-relative arterial approaches in swine.
    Yang ZJ, Ma DC, Wang W, Xu SL, Zhang YQ, Chen B, Zhou F, Zhu TB, Wang LS, Jia EZ, Zhang FM, Cao KJ, Xu ZQ, Ma WZ.
    Clin Chim Acta; 2007 Jun 07; 381(2):114-8. PubMed ID: 17400203
    [Abstract] [Full Text] [Related]

  • 36. Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction.
    Koch M, Spillmann F, Dendorfer A, Westermann D, Altmann C, Sahabi M, Linthout SV, Bader M, Walther T, Schultheiss HP, Tschöpe C.
    Eur J Pharmacol; 2006 Nov 21; 550(1-3):143-8. PubMed ID: 17022964
    [Abstract] [Full Text] [Related]

  • 37. Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction.
    Chen HK, Hung HF, Shyu KG, Wang BW, Sheu JR, Liang YJ, Chang CC, Kuan P.
    Eur J Clin Invest; 2005 Nov 21; 35(11):677-86. PubMed ID: 16269017
    [Abstract] [Full Text] [Related]

  • 38. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia-inducible factor 1 alpha in the heart.
    Czibik G, Wu Z, Berne GP, Tarkka M, Vaage J, Laurikka J, Järvinen O, Valen G.
    Eur J Cardiothorac Surg; 2008 Nov 21; 34(5):976-84. PubMed ID: 18842422
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.